Abstract

Rhabdomyosarcoma (RMS) is a malign tumor originating from mesenchymal cells differentiating to skeletal muscle and constitutes 20% of all solid tumors in children. In the past, radical surgical treatment was the most important mode of treatment, however together with chemotherapy and radiotherapy, organ sparing urgery is currently preferred. In this review, it is aimed to present the treatment options in childhood RMS based on the clinical characteristics, and locations of the tumor.